Source: BIOSPACE

ASCEND: AEterna Zentaris And ASCEND Therapeutics, Inc. Sign Co-Promotion Agreement For U.S. Market

/www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup" ALT"free biotech news">/enewsletters.biospace.com/images/news/cta-latest-biotech-news.jpg" ALIGN"bottom" USEMAP"#cta-BiotechNews" border"0" alt"Get the latest biotech news where you want it. Sign up for the...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Nicholas Hart's photo - President & CEO of ASCEND Therapeutics

President & CEO

Nicholas Hart

CEO Approval Rating

81/100

Read more